clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: glenmark pharmaceuticals inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler glenmark pharmaceuticals inc., usa
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 150 mg/1

Manufacturer
GLENMARK PHARMACEUTICALS INC., USA

Identifiers & Regulatory

Product NDC 68462-143
Product ID 68462-143_25fae384-eedd-4712-afc2-ce2588eaff50
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216957
Listing Expiration 2027-12-31
Marketing Start 2023-03-10

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68462143
Hyphenated Format 68462-143

Supplemental Identifiers

RxCUI
197518 284215 309329
UPC
0368462142011 0368462143018 0368462144015
UNII
T20OQ1YN1W

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number ANDA216957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (68462-143-01)
  • 500 CAPSULE in 1 BOTTLE (68462-143-05)
source: ndc

Packages (2)

Ingredients (1)

clindamycin hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "25fae384-eedd-4712-afc2-ce2588eaff50", "openfda": {"upc": ["0368462142011", "0368462143018", "0368462144015"], "unii": ["T20OQ1YN1W"], "rxcui": ["197518", "284215", "309329"], "spl_set_id": ["8e66de7a-d9d4-4562-bc99-80489d482da4"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68462-143-01)", "package_ndc": "68462-143-01", "marketing_start_date": "20230310"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (68462-143-05)", "package_ndc": "68462-143-05", "marketing_start_date": "20230310"}], "brand_name": "Clindamycin Hydrochloride", "product_id": "68462-143_25fae384-eedd-4712-afc2-ce2588eaff50", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "68462-143", "generic_name": "Clindamycin Hydrochloride", "labeler_name": "GLENMARK PHARMACEUTICALS INC., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clindamycin Hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216957", "marketing_category": "ANDA", "marketing_start_date": "20230310", "listing_expiration_date": "20271231"}